CAS 1467093-03-3

N-[5-[3-[7-(3-Fluorophenyl)-3H-imidazo[4,5-c]pyridin-2-yl]-1H-indazol-5-yl]-3-pyridinyl]-3-methylbutanamide

CAS: 1467093-03-3

Formula: C₂₉H₂₄FN₇O

Purity: 97%

Color and Shape: Solid

Molecular weight: 505.5456

Ref: IN-DA01EO6V

N-(5-(3-(7-(3-Fluorophenyl)-3H-Imidazo[4,5-C]Pyridin-2-Yl)-1H-Indazol-5-Yl)Pyridin-3-Yl)-3-Methylbutanamide

CAS: 1467093-03-3

N-(5-(3-(7-(3-Fluorophenyl)-3H-Imidazo[4,5-C]Pyridin-2-Yl)-1H-Indazol-5-Yl)Pyridin-3-Yl)-3-Methylbutanamide

Purity: 97%

Molecular weight: 505.55g/mol

Ref: 54-PC108693

Adavivint

CAS: 1467093-03-3

Adavivint

Purity: ≥98%

Molecular weight: 505.55g/mol

Ref: 54-BUP12700

Adavivint

CAS: 1467093-03-3

Adavivint (Adavivint (SM04690)) (SM04690) is a Wnt pathway inhibitor.

Formula: C₂₉H₂₄FN₇O

Purity: 98.27% - 98.6%

Color and Shape: Solid

Molecular weight: 505.55

Ref: TM-T5636

Adavivint

Controlled Product

CAS: 1467093-03-3

Formula: C₂₉H₂₄FN₇O

Color and Shape: Neat

Molecular weight: 505.546

Ref: TR-A208260

Adavivint

CAS: 1467093-03-3

Adavivint is a genetically engineered human TNF-α protein. It is a recombinant human tumor necrosis factor alpha (TNF-α) that has been modified to be less immunogenic. Adavivint is not active in the absence of other growth factors and cytokines, but can activate cells in vitro to produce proinflammatory cytokines such as IL-1β, IL-6, IL-8, and IL-12. This protein also activates cell factor and other signaling pathways that lead to the release of intracellular stores of inflammatory molecules. The effective dose for Adavivint is still being determined in clinical trials.

Formula: C₂₉H₂₄FN₇O

Purity: Min. 95%

Molecular weight: 505.55 g/mol

Ref: 3D-SIC09303